Return to homepagePandemic Pact

Novel methods to characterise the determinants of infectious disease transmission from large pathogen sequence datasets, and inform their practical implementation.

Grant number: 321628/Z/24/Z

Grant search

Key facts

  • Disease

    COVID-19, Dengue
  • Start & end year

    2026
    2031
  • Known Financial Commitments (USD)

    $1,124,105.11
  • Funder

    Wellcome Trust
  • Principal Investigator

    Dr. Cécile Tran Kiem
  • Research Location

    United Kingdom
  • Lead Research Institution

    Imperial College London
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen genomics, mutations and adaptations

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Understanding the determinants of pathogen transmission is critical for outbreak control. The unobserved nature of transmission events makes this challenging. Pathogen sequencing can help elucidate transmission patterns, but novel methods are required to manage modern large-scale genome datasets and achieve their potential. Because mutations accrue over time in pathogen genomes, genetically close sequences are informative about transmission events as they are sequenced from epidemiologically linked individuals. I will develop methods leveraging these proximal sequences to characterise transmission between groups. I will build and validate a novel inference framework to estimate the matrix of mixing between age groups from the size and composition of clusters of genetically proximal sequences. Using this framework, I will investigate the role played by different age groups in SARS- CoV-2, seasonal influenza and dengue transmission. I will additionally explore how sampling schemes and sample size impact inferences. Finally, I will demonstrate the use of genetically proximal sequences to estimate vaccine effectiveness against transmission. This work will be applicable across pathogens and transmission determinants. By providing new models to characterise disease transmission from an underutilised data source, this will constitute a critical contribution to inform future epidemic response.